Novo Integrated Sciences, Inc.
NVOS · OTC
8/31/2024 | 5/31/2024 | 2/29/2024 | 11/30/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1 | $2 | $1 | $2 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $3 | $2 | $2 | $3 |
| Inventory | $1 | $1 | $1 | $1 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $5 | $6 | $5 | $7 |
| Property Plant & Equip (Net) | $7 | $7 | $7 | $7 |
| Goodwill | $7 | $8 | $8 | $8 |
| Intangibles | $13 | $15 | $15 | $16 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $27 | $29 | $30 | $30 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $32 | $35 | $35 | $37 |
| Liabilities | – | – | – | – |
| Payables | $3 | $4 | $2 | $3 |
| Short-Term Debt | $3 | $2 | $3 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $2 | $0 |
| Other Curr. Liab. | $8 | $16 | $1 | $4 |
| Total Curr. Liab. | $15 | $23 | $10 | $11 |
| LT Debt | $2 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $1 | $1 | $1 | $1 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $3 | $3 | $3 | $3 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $2 | $2 | $2 |
| Total Liabilities | $18 | $26 | $13 | $14 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$83 | -$88 | -$74 | -$72 |
| AOCI | $1 | $1 | $1 | -$0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $15 | $10 | $22 | $24 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$0 | -$0 | -$0 | -$0 |
| Total Liab. & Tot. Equity | $32 | $35 | $35 | $37 |
| Net Debt | $4 | $1 | $3 | $1 |